참고문헌
- Adam IJ, Mohamdee MO, Martin IG, et al (1994). Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet, 344, 707-11. https://doi.org/10.1016/S0140-6736(94)92206-3
- Azrif M, Ibrahim J, Aslan NM, et al (2011). Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer in a Malaysian Tertiary Hospital. Asian Pac J Cancer Prev, 12, 157-62.
- Bokey EL, Ojerskog B, Chapuis PH, et al (1999). Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: Role of total anatomical dissection. Br J Surg, 86, 1164-70. https://doi.org/10.1046/j.1365-2168.1999.01216.x
- Bosset JF, Collete L, Calaise G, et al (2006). Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med, 355, 1114-23. https://doi.org/10.1056/NEJMoa060829
- Buu TN, Lonnroth K, Quy HT, et al (2003). Initial defaulting in the national tuberculosis programme in HO Chi Minh City, Vietnam: a survey of extent, reasons and alternative actions taken following default. Int J Tuberc Lung Dis, 7, 735-41.
- Chong HY, Taib NA, Rampal S, et al (2010). Treatment options for locally advanced breast cancer - experience in an asian tertiary hospital. Asian Pac J Cancer Prev, 11, 913-17.
- Enker WE, Kemeny N, Shank B, et al (1981). Defining the needs for adjuvant therapy of rectal and colonic cancer. Surg Clin North Am, 61, 1295-310.
- Gerald LCC, Yahaya H, Rampal S (2006). Cancer Incidence in Peninsular Malaysia 2003-2005. National Cancer Registry, The Ministry of Health, Malaysia.
- Gastrointestinal Tumour Study Group (1992): Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol, 10, 549-57.
- Gerard JP, Conray T, Bonnetain F, et al (2006). Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol, 24, 4620-5. https://doi.org/10.1200/JCO.2006.06.7629
- Hill PC, Stevens W, Hill S, et al (2005). Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in the Gambia. Int J Tuberc Lung Dis, 9, 1349-54.
- Kapiteijn E, Marijnen CA, Nagtegaal ID, et al (2001). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 345, 638-46. https://doi.org/10.1056/NEJMoa010580
- Kockerling F, Reymond MA, Schneider C, et al (1998). Prospective multicenter study of the quality of oncologic resections in patients undergoing laparoscopic colorectal surgery for cancer. Dis Colon Rectum, 41, 963-70. https://doi.org/10.1007/BF02237381
- Krook JE, Moertel CG, Gunderson LL, et al (1991). Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med, 324, 709-15. https://doi.org/10.1056/NEJM199103143241101
- Minsky BD, Roedel C, Valentini V (2010). Combined modality therapy for rectal cancer. Cancer J, 16, 253-61. https://doi.org/10.1097/PPO.0b013e3181e0761c
- Peeters KC, Marijnen CA, Nagtegaal ID, et al (2007). The TME trial after a median follow up of 6 years: increases local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg, 246, 693-701. https://doi.org/10.1097/01.sla.0000257358.56863.ce
- Sauer R, Heinz B, Werner H, et al (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351, 1731-40. https://doi.org/10.1056/NEJMoa040694
- Sauer R, Liersch, Merkel, et al (2012). Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow up of 11 years. J Clin Oncol, 30, 1926-33. https://doi.org/10.1200/JCO.2011.40.1836
- Sebag-Montefiore D, Stephens RJ, Steele R, et al (2009). Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicnetre, randomized trial. Lancet, 373, 811-20. https://doi.org/10.1016/S0140-6736(09)60484-0
- van Gijn W, Marijnen CAM, Nagtegaal ID, et al (2011). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicenter, randomized controlled TME trial. Lancet Oncol, 12, 575-82. https://doi.org/10.1016/S1470-2045(11)70097-3
- Wolmark N, Fisher B, Rockette H, et al (1998). Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst, 80, 21-9.
피인용 문헌
- Lymph Node Ratio is an Independent Prognostic Factor in Node Positive Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy Followed by Curative Resection vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5365
- Carbohydrate Antigen 19-9 Levels Associated with Pathological Responses to Preoperative Chemoradiotherapy in Rectal Cancer vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5383
- Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5755
- Can Induction Chemotherapy before Concurrent Chemoradiation Impact Circumferential Resection Margin Positivity and Survival in Low Rectal Cancers? vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2993